Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 11:2:676075.
doi: 10.3389/falgy.2021.676075. eCollection 2021.

Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and Constipation

Mikaela Sekkidou  1 , Leilani Muhardi  2 , Constantina Constantinou  3 , Urszula Kudla  4 , Yvan Vandenplas  5 , Nicolaos Nicolaou  1   3
Affiliations

Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and Constipation

Mikaela Sekkidou et al. Front Allergy. .

Abstract

Background: The majority of mixed-fed infants with non-IgE-mediated cow's milk protein allergy (CMPA) enteropathies are managed with an extensively hydrolysed cow's milk based infant formula (eHF). Given the high variability in peptide distribution of available eHFs, it is important to understand the suitability of a specific product in the management of distinct phenotypes. Objective: To assess the symptom resolution of various phenotypes of clinical manifestations of CMPA enteropathies and constipation managed by a casein-based eHF. Methods: The data of 20 full-term infants (n = 15 with non-IgE-mediated CMPA and n = 5 with constipation) attending a paediatric allergy clinic in Cyprus and managed with a casein-based eHF were retrospectively analysed. Results: Based on the clinical symptoms and history, infants were classified into the following phenotypes: (a) 11/15 (73.3%) FPIAP, (b) 3/15 (20%) FPIES, and (c) 1/15 (6.7%) severe diarrhoea. Overall, 14 (93.3%) patients were successfully managed with the casein-based eHF and 1 (6.7%) required an AAF. This formula was effective in 91% of patients with FPIAP, in 100% with FPIES and with diarrhoea. Three (60%) patients with constipation responded to the eHF. Conclusion: This case-series report supports the efficacy of a particular casein-based eHF for the nutritional management of non-IgE mediated CMPA enteropathies.

Keywords: FPE; FPIAP; FPIES; casein-based extensively hydrolysed infant formula; constipation; non-IgE-mediated CMPA.

PubMed Disclaimer

Conflict of interest statement

MS is a research assistant and NN the Principal Investigator of the Allergy Reduction Trial (A.R.T.) in Cyprus: The cow's milk protein allergy risk reducing effect of Frisolac Gold preventive HA: Multicenter, Placebo-Controlled trial, sponsored by Friesland Campina and conducted at the N Asthma and Allergy Centre. LM and UK are employees of Friesland Campina at the time of drafting and submitting the manuscript. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Flom JD, Sicherer SH. Epidemiology of cow 's milk allergy. Nutrients. (2019) 11:2–14. 10.3390/nu11051051 - DOI - PMC - PubMed
    1. Du Toit G, Meyer R, Shah N, Heine RG, Thomson MA, Lack G, et al. . Identifying and managing cow's milk protein allergy. Arch Dis Child Educ Pract Ed. (2010) 95:134–44. 10.1136/adc.2007.118018 - DOI - PubMed
    1. Allen KJ, Davidson GP, Day AS, Hill DJ, Kemp AS, Peake JE, et al. . Management of cow's milk protein allergy in infants and young children: an expert panel perspective. J Paediatr Child Health. (2009) 45:481–6. 10.1111/j.1440-1754.2009.01546.x - DOI - PubMed
    1. Meyer R, Fleming C, Dominguez-Ortega G, Lindley K, Michaelis L, Thapar N, et al. . Manifestations of Food protein induced gastrointestinal allergies presenting to a single tertiary paediatric gastroenterology unit. World Allergy Organ J. (2013) 6:1. 10.1186/1939-4551-6-13 - DOI - PMC - PubMed
    1. Munblit D, Perkin MR, Palmer DJ, Allen KJ, Boyle RJ. Assessment of evidence about common infant symptoms and cow's milk allergy. JAMA Pediatr. (2020) 174:599–608. 10.1001/jamapediatrics.2020.0153 - DOI - PubMed

LinkOut - more resources